Operasi kanker lambung Dokter Terbaik di Israel - TOP-14 dokter

Profesor Ofer Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – seorang pelopor dalam pengobatan kanker perut dengan kontribusi akademis yang luas.

• Lebih dari 25 tahun spesialisasi dalam onkologi ortopedi
• Terlatih melalui program fellowship di Institut Gustave Roussy – pusat sarkoma terkemuka di Eropa
• Anggota Fakultas ESMO untuk sarkoma jaringan lunak dan tulang
• Telah banyak mempublikasikan karya mengenai imunologi tumor dan pengobatan kanker

Dr. Pelles Sharon berspesialisasi dalam bedah kanker lambung stadium lanjut, termasuk Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Beliau berpraktik di Sourasky Medical Center (Ichilov), sebuah institusi terkemuka dalam perawatan onkologi.

• Pakar dalam prosedur kanker lambung yang kompleks dan invasif minimal
• Melakukan penelitian signifikan mengenai sikap pasien terhadap uji klinis
• Menawarkan rencana perawatan komprehensif termasuk imunoterapi dan terapi target

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Stepfansky memimpin unit rawat inap onkologi di Pusat Medis Tel Aviv, membawa keahlian mendalam dalam bedah kanker lambung.

• Lebih dari 15 tahun berfokus pada onkologi, termasuk penelitian klinis
• Pelatihan khusus di Pusat Medis Tel Aviv
• Direktur rawat inap onkologi sejak 2015
• Berpartisipasi dalam uji klinis lanjutan untuk pengobatan baru

Dr. Ron Greenberg berspesialisasi dalam bedah kanker lambung, melakukan prosedur Whipple terbuka dan minimal invasif di Sourasky Medical Center.

• 20+ tahun pengalaman dalam bedah abdominal
• Memimpin Departemen Bedah Kolorektal di Sourasky
• Ahli dalam teknik bedah kompleks untuk kanker lambung

Salah satu ahli bedah Whipple terkemuka di Israel – Dr. Klauzner berspesialisasi dalam prosedur gastrointestinal kompleks di Sourasky Medical Center.

• Pengalaman bedah lebih dari 45 tahun
• Ketua Bedah di Sourasky Medical Center
• Pakar dalam bedah kolorektal, pankreas, dan gastrointestinal

Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center, berspesialisasi dalam pengobatan kanker lambung dengan pengalaman 33 tahun.

• Kepala Pusat Kanker Gastrointestinal di Rumah Sakit Universitas Hadassah
• Bersertifikasi Dewan (Board-certified) dalam Onkologi dan Radioterapi
• Anggota Perhimpunan Onkologi Klinis Israel dan Asosiasi Kanker Israel
• Fasih berbahasa Inggris dan Ibrani untuk komunikasi pasien yang jelas

Dr. Hirsch berspesialisasi dalam gastroenterologi di Pusat Medis Assuta.

• Berpengalaman dalam kondisi gastrointestinal
• Bekerja di fasilitas medis terkemuka
• Berfokus pada pengobatan kesehatan pencernaan

Dr. Riad Hadad mengepalai departemen hati, pankreas, dan kantong empedu di Klinik Assuta – pusat terkemuka untuk bedah kanker saluran cerna.

• Berspesialisasi dalam perawatan bedah kanker saluran cerna dan hati
• Mendapatkan pelatihan di bidang onkologi di University of Toronto
• Penulis 60 publikasi ilmiah tentang pengobatan kanker
• Anggota masyarakat onkologi bedah Eropa dan Israel

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.